Mpox and HIV: a narrative review

CS Saldana, CF Kelley, BM Aldred… - Current HIV/AIDS Reports, 2023 - Springer
Abstract Purpose of Review We reviewed the available literature on mpox in People with
HIV (PWH). We highlight special considerations of mpox infection related to epidemiology …

Mpox (formerly monkeypox): pathogenesis, prevention, and treatment

J Lu, H Xing, C Wang, M Tang, C Wu, F Ye… - … and Targeted Therapy, 2023 - nature.com
In 2022, a global outbreak of Mpox (formerly monkeypox) occurred in various countries
across Europe and America and rapidly spread to more than 100 countries and regions. The …

[HTML][HTML] Epidemiologic and clinical features of mpox-associated deaths—United States, May 10, 2022–March 7, 2023

AP Riser - MMWR. Morbidity and Mortality Weekly Report, 2023 - cdc.gov
Thirty-eight mpox-associated deaths occurred in the United States during May 10, 2022–
March 7, 2023 (1.3 mpox-associated deaths per 1,000 cases). Most decedents were non …

Multi-omics characterization of the monkeypox virus infection

Y Huang, V Bergant, V Grass, Q Emslander… - Nature …, 2024 - nature.com
Multiple omics analyzes of Vaccinia virus (VACV) infection have defined molecular
characteristics of poxvirus biology. However, little is known about the monkeypox (mpox) …

[HTML][HTML] Tecovirimat resistance in mpox patients, United States, 2022–2023

TG Smith, CM Gigante, NT Wynn… - Emerging Infectious …, 2023 - ncbi.nlm.nih.gov
During the 2022 multinational outbreak of monkeypox virus (MPXV) infection, the antiviral
drug tecovirimat (TPOXX; SIGA Technologies, Inc., https://www. siga. com) was deployed in …

Identification of tecovirimat resistance-associated mutations in human monkeypox virus-Los Angeles County

JM Garrigues, P Hemarajata, A Karan… - Antimicrobial Agents …, 2023 - Am Soc Microbiol
Tecovirimat (also known as TPOXX or ST-246) is a drug available for the treatment of mpox
through the Centers for Disease Control and Prevention's Expanded Access Investigational …

[HTML][HTML] Update on Mpox: a brief narrative review

S Antinori, G Casalini, A Giacomelli… - Le Infezioni in …, 2023 - ncbi.nlm.nih.gov
Mpox (formerly Monkeypox), a neglected tropical disease once confined to Central and West
Africa, emerged as a global epidemic outbreak in May, 2022 with 87,529 cases reported as …

[HTML][HTML] Unveiling the Global Surge of Mpox (Monkeypox): A comprehensive review of current evidence

PM Duarte, RO Adesola, S Priyadarsini, R Singh… - The Microbe, 2024 - Elsevier
Monkeypox, now named mpox, has emerged as a significant public threat, as evidenced by
the 2022 outbreak affecting over seventy countries globally. This infectious disease presents …

Tecovirimat use under expanded access to treat Mpox in the United States, 2022–2023

PA Yu, R Elmor, K Muhammad, YC Yu… - NEJM …, 2024 - evidence.nejm.org
Background During the ongoing outbreak of clade II monkeypox virus (MPXV), many US
patients were prescribed tecovirimat, an antiviral drug that was made available under an …

[HTML][HTML] Clinical review of human mpox

D Ogoina, I Damon, E Nakoune - Clinical Microbiology and Infection, 2023 - Elsevier
Background Historically, human mpox was predominantly a zoonotic disease occurring
more frequently in rural children in Africa and characterized by a largely self-limiting febrile …